Physician profile
Alexander Aleem
NPI 1326369265
$230,091.59
in general payments reported to CMS, 2019-2025
6 companies · $61K in 2025
The $61K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,670 · 2020: $272 · 2021: $14K · 2022: $50K · 2023: $46K · 2024: $55K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $135K · Travel and Lodging: $21K · Food and Beverage: $4,729 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $134,775.00 |
| Travel and Lodging | $21,048.10 |
| Food and Beverage | $4,728.93 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $223,548.71 | 2021-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform Reversed |
| Elite Orthopedics, LLC | $3,676.37 | 2019-2024 | |
| Synthes Gmbh | $2,318.12 | 2025 | |
| Wright Medical Technology, INC. | $320.53 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $114.82 | 2020 | |
| Acumed LLC | $113.04 | 2024 | Acumed, Innate Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Aleem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.